News Focus
News Focus
Post# of 257580
Next 10
Followers 142
Posts 23980
Boards Moderated 0
Alias Born 06/13/2011

Re: biomaven0 post# 227878

Sunday, 12/22/2019 2:48:24 PM

Sunday, December 22, 2019 2:48:24 PM

Post# of 257580
bio. as a follow up . As per the Teva settlement with AMRN ...they can enter if another generic prevails in any patent challenge . The key then will be who can lock up the remaining large API suppliers via supply exclusivity agreements
Kiwi

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today